Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Ultimately, the six variables of Age (OR = 1.043, 95% CI (1.035, 1.052), p < 0.001); 25(OH)D3 (OR = 0.887, 95% CI (0.854, 0.921), p < 0.001); Duration of T2DM (OR = 1.151, 95% CI (1.134, 1.169), p < 0.001); HDL (OR = 0.993, 95% CI (0.99, 0.996), p < 0.001); HbA1c (OR = 1.309, 95% CI (1.251, 1.372); and FBG (OR = 1.060, 95% CI (1.027, 1.094), 0.003) were statistically significant and hence selected for the development of the prediction model (Table 2).

Source: 3.2. Screening for Predictive Factors. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The inclusion criteria were as follows: (a) patients at least 18 years old, (b) the diagnostic criteria for T2DM was based on the Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2013 edition) [], and (c) all research participants were able to communicate independently.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Training and External Validation of a Predict Nomogram for Type 2 Diabetic Peripheral Neuropathy

Study design awaiting verification · Diagnostics · 2023

Original publication title

Training and External Validation of a Predict Nomogram for Type 2 Diabetic Peripheral Neuropathy

Yongsheng Li; Yongnan Li; Ning Deng; Haonan Shi; Siqingaowa Caika; Gan Sen

© 2023 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background:

Diabetic peripheral neuropathy (DPN) is a critical clinical disease with high disability and mortality rates. Early identification and treatment of DPN is critical. Our aim was to train and externally validate a prediction nomogram for early prediction of DPN.

Methods:

3012 patients with T2DM were retrospectively studied. These patients were hospitalized between 1 January 2017 and 31 December 2020 in the First Affiliated Hospital of Xinjiang Medical University in Xinjiang, China. A total of 901 patients with T2DM from the Suzhou BenQ Hospital in Jiangsu, China who were hospitalized between 1 January 2019 and 31 December 2020 were considered for external validation. The least absolute shrinkage and selection operator (LASSO) and multivariate logistic regression were performed to identify independent predictors and establish a nomogram to predict the occurrence of DPN. The performance of the nomogram was evaluated using a receiver operating characteristic curve (ROC), a calibration curve, and a decision curve analysis (DCA).

Findings:

Age, 25-hydroxyvitamin D3 [25(OH)D3], Duration of T2DM, high-density lipoprotein (HDL), hemoglobin A1c (HbA1c), and fasting blood glucose (FBG) were used to establish a nomogram model for predicting the risk of DPN. In the training and validation cohorts, the areas under the curve of the nomogram constructed from the above six factors were 0.8256 (95% CI: 0.8104 to 0.8408) and 0.8608 (95% CI: 0.8376 to 0.8840), respectively. The nomogram demonstrated excellent performance in the calibration curve and DCA.

Interpretation:

This study has developed and externally validated a nomogram model which exhibits good predictive ability in assessing DPN risk among the type 2 diabetes population. It provided clinicians with an accurate and effective tool for the early prediction and timely management of DPN.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Diabetic peripheral neuropathy (DPN) is a critical clinical disease with high disability and mortality rates. Early identification and treatment of DPN is critical. Our aim was to train and externally validate a prediction nomogram for early prediction of DPN.

Source: Background:

Abstract: Findings

Age, 25-hydroxyvitamin D3 [25(OH)D3], Duration of T2DM, high-density lipoprotein (HDL), hemoglobin A1c (HbA1c), and fasting blood glucose (FBG) were used to establish a nomogram model for predicting the risk of DPN. In the training and validation cohorts, the areas under the curve of the nomogram constructed from the above six factors were 0.8256 (95% CI: 0.8104 to 0.8408) and 0.8608 (95% CI: 0.8376 to 0.8840), respectively. The nomogram demonstrated excellent performance in the calibration curve and DCA.

Source: Findings:

Abstract: Interpretation

This study has developed and externally validated a nomogram model which exhibits good predictive ability in assessing DPN risk among the type 2 diabetes population. It provided clinicians with an accurate and effective tool for the early prediction and timely management of DPN.

Source: Interpretation:
Authors’ abstract

Background:

Diabetic peripheral neuropathy (DPN) is a critical clinical disease with high disability and mortality rates. Early identification and treatment of DPN is critical. Our aim was to train and externally validate a prediction nomogram for early prediction of DPN.

Methods:

3012 patients with T2DM were retrospectively studied. These patients were hospitalized between 1 January 2017 and 31 December 2020 in the First Affiliated Hospital of Xinjiang Medical University in Xinjiang, China. A total of 901 patients with T2DM from the Suzhou BenQ Hospital in Jiangsu, China who were hospitalized between 1 January 2019 and 31 December 2020 were considered for external validation. The least absolute shrinkage and selection operator (LASSO) and multivariate logistic regression were performed to identify independent predictors and establish a nomogram to predict the occurrence of DPN. The performance of the nomogram was evaluated using a receiver operating characteristic curve (ROC), a calibration curve, and a decision curve analysis (DCA).

Findings:

Age, 25-hydroxyvitamin D3 [25(OH)D3], Duration of T2DM, high-density lipoprotein (HDL), hemoglobin A1c (HbA1c), and fasting blood glucose (FBG) were used to establish a nomogram model for predicting the risk of DPN. In the training and validation cohorts, the areas under the curve of the nomogram constructed from the above six factors were 0.8256 (95% CI: 0.8104 to 0.8408) and 0.8608 (95% CI: 0.8376 to 0.8840), respectively. The nomogram demonstrated excellent performance in the calibration curve and DCA.

Interpretation:

This study has developed and externally validated a nomogram model which exhibits good predictive ability in assessing DPN risk among the type 2 diabetes population. It provided clinicians with an accurate and effective tool for the early prediction and timely management of DPN.

Publication and source details

Original title: Training and External Validation of a Predict Nomogram for Type 2 Diabetic Peripheral Neuropathy

Yongsheng Li; Yongnan Li; Ning Deng; Haonan Shi; Siqingaowa Caika; Gan Sen

Diagnostics · 2023

* Correspondence: sengan99@163.com
†

These authors have contributed equally to this work.

© 2023 by the authors.2023https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Natural Science Foundation of Xinjiang Uygur Autonomous Region2022D01C184This study was also supported by the Natural Science Foundation of Xinjiang Uygur Autonomous Region (Grant Number, 2022D01C184).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T07:30:47.532823+00:00

DOI: 10.3390/diagnostics13071265 · PMC10093299